Skip to content

Clinical trials

Completed Lymphangioleiomyomatosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphangioleiomyomatosis Status: Completed Country / region: United States Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20051
20062
20071
20091
20101
20111
20121
20142
20161
20171
20182
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)5
University of Cincinnati3
Brigham and Women's Hospital2
Children's Hospital Medical Center, Cincinnati2
Novartis Pharmaceuticals2
Medical University of South Carolina1
Tony Eissa1
University of Pennsylvania1
Vanderbilt University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphangioleiomyomatosis18
Tuberous Sclerosis6
Ascites2
Hereditary Sensory and Autonomic Neuropathies2
Lymphangiomyoma2
Angiomyolipoma1
Asthma1
Astrocytoma1
Chylothorax1
Chylous Ascites1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.